Kennedys Patent Company Profile

15:22 EDT 24th September 2018 | BioPortfolio

Kennedys Patent is a firm of Chartered Patent & Trademark Attorneys. Our business was built on the belief that Intellectual Property is viewed not in isolation, but is integral to the business strategy.Kennedys Patent, which set up only in 1997, now has a staff of 25, offices in Glasgow, Aberdeen and Newcastle and year on year growth of over 40%. It has a client list that boasts multinationals, international research institutions and some of Scotland's most well known and successful early stage companies.


185 St Vincent Street
G2 5QD
United Kingdom


Phone: (44) 141 226 6826
Fax: (44) 141 226 6838

News Articles [415 Associated News Articles listed on BioPortfolio]

Linking the scientific and patent literatures

The scientific literature and patent literature have for a long time been viewed as two different worlds, with publications in the latter one measure of a researcher’s translational activity. But a ...

European Patent Office: Patent Filing and Advice for Applicants

In this episode of PharmaTelevision News Review, Fintan Walton talks with Fredrik Aslund at the European Patent Office. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • What pa...

Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

European Patent Office Revokes Edwards Lifesciences '550 Patent MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it, along with sever...

Berkeley CRISPR Inventors Get Another Important European Patent

This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.

Walmart mit weiterem Blockchain-Patent

Der US-Einzelhandelsgigant Walmart hat, gemäß einer Patentanmeldung, die von dem U.S. Patent and Trademark Office veröffentlicht wurde, ein weiteres Patent erhalten, diesmal für ein System, das me...

RedHill BioPharma Receives New Patent

RedHill Biopharma received a notice of allowance from the US patent and Trademark Office on Monday (August 20) for a new formulation patent covering RHB-106, which will be valid until 2033. The post R...

Indivior files patent lawsuits against Teva, Dr Reddy's and others

Indivior has filed patent lawsuits against Dr. Reddy's, Actavis, Par, Alvogen and Teva for infringement of United States Patent No. 9,931,305 (the '305 patent) relating to their respective proposed ge...

nChain Receives First Patent Grant for Blockchain-Enforced Smart Contract Invention

The patent – European Patent Office number EP3257191 - is entitled " A method and system for securing computer software using a distributed hash table Read more...

Drugs and Medications [99 Associated Drugs and Medications listed on BioPortfolio]

Indomethacin [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Indomethacin for Injection safely and effectively. See full prescribing information for Indomethacin for Injection. Indomethacin for I...

Migralex [Migralex Inc.]

Migralex Labeling

Dial professional antibacterial hand sanitizer [The Dial Corporation]

Drug Facts

Prevail-fx 2 one step [Productos Urologos de Mexico, S.A. de C.V.]

Drug Facts

Trioxin [Vertical Pharmaceuticals, Inc]


PubMed Articles [137 Associated PubMed Articles listed on BioPortfolio]

Patent term restoration for top-selling drugs in the USA.

Patents temporarily protect brand-name drugs from generic competition, but some of the 20-year patent term is used up before marketing approval. To compensate for patent life lost to clinical testing ...

Indian pharmaceutical patent prosecution: The changing role of Section 3(d).

India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of "secondary" phar...

Do patents of academic funded researchers enjoy a longer life? A study of patent renewal decisions.

This paper assesses the extent to which patent renewal data is associated with government funding in a university context by focusing on the relationship between the funded patentees and renewal decis...

The influence of four or more patent lumbar arteries on persistent type II endoleak and sac expansion after EVAR.

This study aimed to review our clinical results and determine how preoperative patent lumbar arteries (LAs) influence the occurrence of type II endoleaks or aneurysm sac enlargement after endovascular...

Feasibility of patent and proprietary medicine vendor provision of injectable contraceptives: preliminary results from implementation science research in Oyo and Nasarawa, Nigeria.

Nigerian policymakers are debating task-shifting injectable contraceptive services to Patent and Proprietary Medicine Vendors (PPMVs).

Clinical Trials [142 Associated Clinical Trials listed on BioPortfolio]

The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI

The primary objective is to evaluate if patent foramen ovale (PFO) closure and antiplatelet medical management can reduce the risk of recurrent stroke or transient ischemic attack (TIA) wh...

Paracetamol And Ibuprofen in Closing Patent Ductus Arteriosus

The purpose of this pilot trial is to study efficacy and safety of simultaneous intravenous (iv) ibuprofen and paracetamol medications in the closure of patent ductus arteriosus (PDA) in p...


Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and ...

Lifetech CeraFlex™ Post-Market Surveillance Study

The purpose of this multi-center, interventional, prospective, post-market study is to collect real world data on patient outcomes and evaluate the procedural success and performance of th...

Hip Fracture and Patent Foramen Ovale

Ereth et al. showed in 1992, using transesophageal echocardiography, that the implantation of a hip prosthesis may be complicated by intracardiac embolization of various origin. A patent ...

Companies [473 Associated Companies listed on BioPortfolio]

Kennedys Patent

Kennedys Patent is a firm of Chartered Patent & Trademark Attorneys. Our business was built on the belief that Intellectual Property is viewed not in isolation, but is integral to the business strateg...

RGC Jenkins & Co

We are a leading firm of patent and trademark agents with offices in London, Munich and Alicante. We are qualified to represent clients before the UK Patent Office, the European Patent Office, the Ger...

Sunlight Research, LLC

Sunlight Research(TM) is the premier source for up-to-date Patent Data Analysis, Patent Claims Coverage Reports, Intellectual Property Market Research, Patent Analysis, Non-Practicing Entities Patent ...


A start-up biomedical company with a novel approach to treating cancer. Our approach is logical. There are specific chemicals associated with tumors which block immune attack. By neutralizing these ...

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH...

More Information about "Kennedys Patent" on BioPortfolio

We have published hundreds of Kennedys Patent news stories on BioPortfolio along with dozens of Kennedys Patent Clinical Trials and PubMed Articles about Kennedys Patent for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kennedys Patent Companies in our database. You can also find out about relevant Kennedys Patent Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record